Advances in the Endoscopic Assessment of Inflammatory Bowel Diseases: Cooperation between Endoscopic and Pathologic Evaluations by 천재희
209
© 2015 The Korean Society of Pathologists/The Korean Society for Cytopathology
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ 
by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
pISSN 2383-7837
eISSN 2383-7845
Advances in the Endoscopic Assessment of Inflammatory Bowel Diseases: 
Cooperation between Endoscopic and Pathologic Evaluations
Jae Hee Cheon
Department of Internal Medicine,  
Yonsei University College of Medicine,  
Seoul, Korea
Endoscopic assessment has a crucial role in the management of inflammatory bowel disease 
(IBD). It is particularly useful for the assessment of IBD disease extension, severity, and neoplasia 
surveillance. Recent advances in endoscopic imaging techniques have been revolutionized over 
the past decades, progressing from conventional white light endoscopy to novel endoscopic tech-
niques using molecular probes or electronic filter technologies. These new technologies allow for 
visualization of the mucosa in detail and monitor for inflammation/dysplasia at the cellular or sub-
cellular level. These techniques may enable us to alter the IBD surveillance paradigm from four 
quadrant random biopsy to targeted biopsy and diagnosis. High definition endoscopy and dye-
based chromoendoscopy can improve the detection rate of dysplasia and evaluate inflammatory 
changes with better visualization. Dye-less chromoendoscopy, including narrow band imaging, 
iScan, and autofluorescence imaging can also enhance surveillance in comparison to white light 
endoscopy with optical or electronic filter technologies. Moreover, confocal laser endomicroscopy 
or endocytoscopy have can achieve real-time histology evaluation in vivo and have greater accu-
racy in comparison with histology. These new technologies could be combined with standard en-
doscopy or further histologic confirmation in patients with IBD. This review offers an evidence-
based overview of new endoscopic techniques in patients with IBD.
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Inflammatory bowel disease (IBD) includes Crohn’s disease 
(CD) and ulcerative colitis (UC), is a chronic, relapsing inflam-
matory disease in the gastrointestinal tract. The cause of IBD is 
unknown. It has been suggested that genetic, environmental, and 
immunologic factors are involved in the pathogenesis of IBD, 
but the precise etiologic mechanisms remain unclear. 
Diagnostic and therapeutic approaches for IBD have evolved 
over the past decades, but precise diagnosis and assessment of 
disease status is still an important matter of concern for physi-
cians and IBD specialists. Precise diagnosis and assessment of 
patients with IBD is particularly difficult because medical thera-
pies, surgical approaches, and long-term prognosis differ by IBD 
subtypes, even if patients have similar signs and symptoms. 
The most valuable tool for primary diagnosis of IBD is endo-
scopic assessment with tissue sampling.1,2 It can be used to ob-
serve inflammatory changes in the intestinal mucosa, evaluate 
the extent of disease. It also plays a role in assessing treatment 
efficacy in terms of mucosal healing and the risk of postsurgical 
recurrence. Importantly, colonoscopy with random biopsy is es-
sential to endoscopic diagnosis, management, and treatment of 
IBD. The relationship between longstanding IBD and increased 
colorectal cancer (CRC) risk has been well established.3 CRC is 
regarded as the primary cause of death in up to 15% of IBD pa-
tients. The overall rate of CRC in UC patients is 3.7% with cu-
mulative probabilities of 18% by 30 years, according to a meta-
analysis of 116 studies on the subject.4 There is also a 2–3 fold 
increased risk of CRC in CD than in patients without IBD 18.3 
years after initial CD diagnosis.5 Recent studies suggest a de-
creased risk of CRC in IBD patients as highly developed endo-
scopic surveillance techniques have been adopted. According to 
a one time-trend study, the relative risk of CRC decreased from 
1.34 in 1979–1988 to 0.57 in 1999–2008.6 In this sense, prop-
er cancer surveillance with conventional and novel endoscopic 
techniques has major clinical implications for patients with 
IBD.7 
Generally, the standard recommendations for random biopsy 
in surveillance colonoscopy for IBD patients include four quad-
rant biopsies taken every 10 cm. These biopsies generally begin 
8 to 10 years after diagnosis. Extra biopsies can be obtained from 
strictured, raised, or color changed areas in the colorectum.8-13 
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However, these biopsies can be time consuming and laborious. 
Recent endoscopic techniques are evolving with the aim of visu-
alizing detailed surface architecture of the mucosa, vascular pat-
terns, and even the cellular and subcellular structures in real time. 
Precise observation and targeted biopsy are possible with the 
progress of technologies such as high definition endoscopy, nar-
row band imaging, chromoendoscopy, confocal endomicroscopy, 
etc. The present review focuses on novel endoscopic technolo-
gies and diagnostic strategies for inflammation and dysplasia in 
IBD patients. 
RECENT DEVELOPMENT OF TECHNIQUES 
FOR ENDOSCOPY IN INFLAMMATORY  
BOWEL DISEASE
Endoscopic techniques have led to improved observation of 
mucosal details, which may lead to reduced random biopsies 
since biopsies will be able to be targeted for histological evalua-
tion. These techniques include image enhancement with modi-
fying conventional endoscopy and improvement in mucosal im-
aging with magnification or several optical techniques (Table 1). 
Each of these techniques is at a different stage of development 
and use in clinical medicine. Some of the equipment, such as 
probe-based or scope-based confocal laser techniques or endocy-
toscopy, are available only in specialized academic centers, 
whereas high definition endoscopy has become the standard and 
is widely used in clinical practice. In addition, specialized train-
ing and adequate clinical experience are necessary to adequately 
perform these novel endoscopies. In the case of image-enhanced 
endoscopy, it is important to prepare the patient with bowel 
cleansing in order to ensure the efficacy and safety of the proce-
dure prior to use. This technique should be used to visualize a 
specific area in detail rather than for observation of the entire co-
lon. Each of the advanced endoscopies has their own advantages 
and limitations. These techniques are far from being used as the 
gold standard in IBD, and some studies have been controver-
sial. Thus, it requires more experience before implementing 
them in clinical practice and cautious use for patients on clinical 
use.
High definition endoscopy
High definition or high resolution endoscopy presents signal 
images with 850,000 to 1 million pixels, while standard defini-
tion signals offer 100,000 to 400,000 pixels on an SD format.14,15 
High resolution endoscopy results in visualization of subtle mu-
cosal details and improves the sensitivity and specificity of dys-
plastic lesion detection. Furthermore, it facilitates endoscopic 
resection by delineating borders of neoplastic lesions in IBD 
patients. 
The majority of published data comes from non-IBD patients 
and found high definition endoscopy to be superior compared 
with conventional endoscopy. A retrospective study with 160 
colonoscopies including long-standing (> 7 years) colonic IBD 
patients demonstrated 2.21 greater likelihood (95% confidence 
interval [CI], 1.09 to 4.45) adjusted prevalence ratio of detect-
ing any dysplastic lesions and 2.99 (95% CI, 1.16 to 7.79) of 
detecting dysplastic lesions on targeted biopsy with high defi-
nition colonoscopy compared to conventional endoscopy.16 There 
was also a 3-fold higher neoplasia detection rate with high defi-
nition endoscopy when compared with standard definition en-
doscopy in IBD patients.
Chromoendoscopy
Chromoendoscopy is considered a cost-effective technique in-
tended to enhance visualization of mucosal detail, submucosal 
vascular patterns, and lesion characterization. In particular, chro-
moendoscopy can facilitate the identification of flat lesions har-
boring intraepithelial neoplasia. With this, it can guide biopsies 
and reduces the number of biopsies. It is divided into dye-based 
and dye-less imaging techniques. 
Dye-based chromoendoscopy has been used for over a decade 
and increases the rate of dysplastic lesion detection, especially in 
patients with long-standing IBD (Fig. 1A). In addition, Dye-
based chromoendoscopy allows for improved assessment of dis-
ease severity and extent. Absorptive agents (e.g., Lugol solution, 
methylene blue, toludine blue, and cresyl violet), contrast agents 
(e.g., indigo carmine and acetic acid), agents for tattooing (e.g., 
India ink, Indocyanine green, and methylene blue), and reactive 
Table 1. Categories of endoscopic techniques used in inflamma-
tory bowel disease
Category Endoscopic technique
White light endoscopy Standard definition colonoscopy
High definition colonoscopy
Water immersion colonoscopy
Dye-based image enhanced 
  endoscopy
Chromoendoscopy with absorptive 
  agents, contrast agents, tattooing, 
  reactive staining agents
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staining agents (e.g., congo red and phenol red) can be used in 
dye-based chromoendoscopy.17,18 Several studies have shown the 
superiority of chromoendoscopy compared to conventional white 
light endoscopy. Dye-based chromoendoscopy has a moderate 
to high sensitivity for diagnosis, improved dysplasia detection, 
and prediction of mucosal change using magnification tech-
niques (Fig. 1B). Two meta-analyses also demonstrated the su-
periority of targeted biopsy with dye-based chromoendoscopy 
in diagnosing and assessing mucosal ulcerations and dyspla-
sia19,20 while reducing the number of biopsies. Most recently, 
Soetikno et al.20 included 665 patients from 6 studies and con-
firmed that the rate of detection of any dysplasia was approxi-
mately 9 times higher with dye-based chromoendoscopy with 
targeted biopsy than using white light endoscopy, with an 8.9 
pooled odds ratio (95% CI, 3.4 to 23.0). When comparing the 
difference in the mean procedure time, dye-based chromoendos-
copy is 10.9 minutes shorter than white light endoscopy, includ-
ing the time spent on random biopsies.
Dye-less chromoendoscopy is a novel imaging technology 
that allows for a detailed examination of both the mucosal sur-
face and the mucosal vascular pattern by pushing a button on 
the handle of the endoscope, thereby enabling high-contrast im-
aging of the mucosal surface in real time without the use of spe-
cial equipment. These dye-less chromoendoscopy techniques are 
divided into two types. One is an optical filter system including 
narrow band imaging (NBI) from Olympus, Tokyo, Japan and 
Compound Band Imaging from Aohua, Shanghai, China, and 
the other is digital chromoendoscopy with a post-processing sys-
tem including i-Scan from Pentax, Tokyo, Japan and FICE (Fuji 
intelligent color enhancement from Fujinon, Tokyo, Japan).21,22
Optical chromoendoscopy techniques are based on optical 
lenses integrated within the light source of the endoscope, usu-
ally in front of the excitation white light source, to narrow the 
bandwidth in the blue and green regions of the spectrum.23,24 
In contrast, digital chromoendoscopy uses digital postprocessing 
of endoscopic images made in real-time by the video processor.25 
Recent studies indicate that dye-less chromoendoscopy, includ-
ing optical and digital ones, are useful and practical for the dif-
ferentiation of adenoma versus hyperplastic colon polyps and 
have good histological correlations.26-28
Narrow band imaging
NBI is the most recognized among the virtual chromoendos-
copy. This in vivo method uses optical filters in front of the light 
source to narrow the wavelength of the projected light to a 30 
nm wide blue (415 nm) and green (540 nm) spectra, which en-
ables visualization of micro-vessel morphological changes in su-
perficial neoplastic lesions. NBI enhances the visibility of the 
small irregularities that accompany non-neoplastic inflammato-
ry changes using the same logic as dye-based chromoendoscopy 
(Fig. 2). 
However, the role of NBI in detecting dysplasia in IBD re-
mains somewhat uncertain due to conflicting results in the lit-
erature. A paper by East et al.29 was the first to describe the use 
of NBI to distinguish dysplastic from nondysplastic mucosa in 
patients with longstanding. Subsequent to this case report, sev-
eral randomized controlled studies have been published. Dekker 
et al.30 demonstrated that NBI does not improve the detection 
rate of neoplasia in UC compared with high-definition white 
light endoscopy with a randomized crossover study of 42 patients. 
Of 11 patients with neoplastic lesions, four were detected with 
both modalities, four with NBI alone, and three with standard 
A B
Fig. 1. Chromoendoscopy using indigocarmine (A) and combined with magnification technique (B) for colonic dysplasia in ulcerative colitis 
(Courtesy of Dr. Jeong-Sik Byeon at Asan Medical Center).
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white light colonoscopy alone. 
Two additional randomized trials comparing NBI to white 
light endoscopy also found no significant difference in the de-
tection of neoplastic lesions. Random background biopsies were 
also ineffective in detecting dysplasia. According to Ignjatovic 
et al.,31 dysplasia detection was 9% in each arm and the yield of 
dysplasia detection from random nontargeted biopsies was 
0.04%. Van den Broek et al.32 found 13 of 16 neoplastic lesions 
(81%) using high definition-NBI compared with 11 of 16 neo-
plastic lesions (69%) using high definition -white light endosco-
py. A study using a new-generation NBI system compared with 
dye based chromoendoscopy for the early detection of colitis-as-
sociated dysplasia and cancer in patients with longstanding co-
lonic IBD demonstrated that NBI is less time-consuming (26.87 ± 
9.89 minutes vs 15.74 ± 5.62 minutes, p < .01), but has no ad-
vantages over conventional endoscopy for the detection of in-
traepithelial neoplasia.33 However, NBI has some advantages 
over dye-based chromoendoscopy, as it does not require addi-
tional dye agents and is easier to use in practice. These findings 
have led to controversy regarding the real role of NBI in dys-
plasia detection in IBD patients.
i-Scan
Currently, two virtual chromoendoscopy techniques are avail-
able, including FICE and i-Scan is a new endoscopic system us-
ing post processing light filter technology based on software al-
gorithms with real time image mapping. It enhances different 
elements of the mucosa by three different image processes such 
as surface enhancement, tone enhancement, and contrast en-
hancement. Activation between different modes is done by 
pushing a button on the handle of the endoscope.34,35 To date, 
most randomized trials have not shown that NBI or FICE can 
improve the detection of colorectal neoplasia when comparing 
colonoscopy with and without filter enhancement. 
A randomized controlled study was conducted on 78 IBD pa-
tients in Germany to identify whether i-Scan has the potential 
to enhance assessment of disease severity and extent in mild or 
inactive IBD patients. The average duration of the examination 
for high definition—white light endoscopy and i-Scan groups 
was 18 and 20.5 minutes, respectively, but these differences 
were not statistically significant. When comparing the endo-
scopic prediction of inflammatory extent and activity with the 
histological results, there was overall agreement of 48.71% and 
53.85% in the high definition—white light endoscopy group 
and 92.31% and 89.74% in the i-Scan group (p < .001 and p = 
.066).36
Patients with intestinal food allergy present with lymphoid 
hyperplasia, slight mucosal edema, and blurred mucosal vascu-
lar pattern in the colon. Based on this, an observational study re-
ported on the potential of i-Scan for prediction of mucosal chang-
es with suspected food allergy. Positive and negative predictive 
values for i-Scan to predict food allergy were 92% and 80%, re-
spectively. Moreover, i-Scan predicted food allergy with a sensi-
tivity, specificity, and accuracy of 85%, 89%, and 86%, respec-
tively.37 
Confocal laser endomicroscopy
Observation and characterization of the colonic mucosal sur-
face and abnormalities of blood vessel architecture are crucial in 
predicting histology, and this can be performed more efficiently 
with chromoendoscopy. However, histologic confirmation is 
needed to determine whether the presence of mucosal abnor-
malities is a result of IBD or not. This can be accomplished by 
confocal endomicroscopy in vivo, which may provide images 
similar to histologic findings in real time (Fig. 3). Endomicros-
copy is regarded as optical biopsy that can achieve an image of 
A B C
Fig. 2. Observation findings of colonic dysplasia using white light endoscopy (A), narrow band imaging technique (B), and autofluorescence 
imaging technique (C) in ulcerative colitis (Courtesy of Dr. Jeong-Sik Byeon at Asan Medical Center).
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the cellular structure of the mucosa with 1,500 fold magnifica-
tion.38 Currently, two endomicroscopy systems are available in-
cluding an integrated endoscopy system (iCLE, Pentax) and a 
probe-based system (pCLE, Cellvizio, Mauna Kea Technologies, 
Paris, France). In vivo CLE uses an excitation wavelength of 488 
nm with a single line laser; the laser power output is up to 1 
mW at the tissue surface. Images are collected at a scan rate of 
0.8 frames per second at a resolution of 1,024 × 1,024 pixels or 
1.6 frames per second with 1,024 × 512 pixels.39 It can capture 
the z axis which enables interrogation of the epithelium and 
lamina propria 0–250 mm below the surface layer.40 The pCLE-
system uses a fixed laser power and a fixed image plane depth. 
The purpose of the system is to observe mucosal microarchitec-
ture with an increased field of view (4 × 2 mm) through postpo-
cessing with Cellvio Viewer (Fig. 4A). It enables virtual stain-
ing of mucosal structures to further enhance tissue contrast. The 
probe requires an accessory channel of 2.8 mm and has a resolu-
tion of 1 μm with a field of view of 240 μm and a fixed image 
plane depth varying between 55–65 μm (Fig. 4B). 
Crypt architecture, microvascular alterations, fluorescein 
leakage, and cellular infiltrates within the lamina propria are 
important observational markers in CLE evaluation.12,41-44 CLE 
can aid in demonstrating mucosal healing in terms of deep re-
mission beyond the absence of mucosal ulceration.
Watanabe et al.45 investigated the features of CLE in the in-
flamed and noninflamed rectal mucosa of 17 UC patients and 
compared these results to standard histology. In this study, the 
crypts of colonic mucosa in active UC were large, variously 
shaped and irregular in arrangement. Numerous inflammatory 
cells and capillaries were visible in the lamina propria with CLE. 
Li et al.42 also assessed crypt architecture, fluorescein leakage, 
and microvascular alterations in 73 consecutive UC patients and 
showed a correlation with histological results (p < .001). On 
post-CLE objective assessment, subjective architectural classifi-
cations were supported by the number of crypts per image (p < 
.001), but not fluorescein leakage results by gray scale (p = .194). 
Most recently, CLE also proved a sensitive tool in predicting UC 
relapse. In this study, 17 of 20 patients (85%) with histologi-
cally confirmed normal or chronic inflammation were diagnosed 
as having nonactive inflammation by real-time CLE. Twenty 
two of 23 patients (96%) with histologically confirmed acute 
inflammation were diagnosed as having active inflammation by 
CLE. The results of CLE were highly consistent with those of 
conventional histology (kappa value = 0.812). Eleven percent of 
patients in the nonactive inflammation group relapsed, while 
64% of patients in the active inflammation group relapsed. The 
relapse rate of patients with active inflammation was signifi-
cantly higher than of those with nonactive inflammation (p < 
.001).
Neumann et al.46 proposed the Crohn’s Disease Endomicro-
scopic Activity Score for assessing CD activity in vivo from com-
parison data between CD patients and a normal control group 
with standard white-light endoscopy followed by CLE. Active 
CD patients showed a higher proportion of increased colonic 
crypt tortuosity, enlarged crypt lumens, microerosions, aug-
mented vascularization, and increased cellular infiltrates within 
the lamina propria. In the case of quiescent CD patients, there 
was a significant increase in crypt and goblet cell number com-
pared with controls. 
Autofluorescence imaging
Autofluorescence imaging (AFI) is a technique using the nat-
ural principle that cells contain molecules that become fluores-
cent when excited by UV/Vis radiation of a certain wavelength. 
Among the endogenous fluorophores, collagen and elastin have 
A B
Fig. 4. Cellvizio system for probe based confocal laser endomi-
croscopy (A) and a probe (B).
A B
Fig. 3. Confocal laser endomicroscopic findings for normal muco-
sa (A) and mucosa in active ulcerative colitis (B). In ulcerative coli-
tis, lamina propria widening, inflammatory infiltrates, goblet cell de-
pletion, and crypt distortion are observed.
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a relatively high quantum yield, so the extracellular matrix usu-
ally contributes to the autofluorescence emission more than cel-
lular components. Autofluorescence imaging videoendoscopy 
produces real-time pseudo-color images based on tissue autoflu-
orescence emitted by excitation of endogenous tissue fluoro-
phores. 
It is well known that cell and tissue state change resulting 
from modifications of the amount and distribution of endoge-
nous fluorophores and the chemical-physical properties of their 
microenvironment during physiological and/or pathological 
processes. Therefore, AFI can be utilized in order to obtain in-
formation about the morphological and physiological state of 
cells and tissues (Fig. 2).
AFI has been used to highlight various lesions, such as neo-
plastic tissue, minimal changes in reflux esophagitis, the extent 
of chronic atrophic fundal gastritis, and Barrett’s esophagus.47-50 
AFI improves detection rates of neoplasia in patients with IBD 
and decreases the number of random biopsies needed. In a ran-
domized, comparative study with 50 UC patients, neoplasia 
miss-rates for AFI and white light endoscopy were 0% and 50%, 
respectively (p = .036).51 AFI had 100% of sensitivity since all 
neoplasia was colored purple on AFI, while NBI had a 75% of 
sensitivity according to the Kudo classification.
AFI also has the ability to detect inflammatory lesions, in-
cluding microscopic activity, in the colonic mucosa. Osada et al.52 
evaluated 572 images from 42 UC patients including white 
light endoscopy and AFI to validate the clinical relevance of 
AFI endoscopy for the assessment of the severity of inflamma-
tion. The green color component of AFI corresponded more 
closely with mucosal inflammation sites (r = –0.62, p < .01) than 
the red (r = 0.52, p < .01) or blue (r = 0.56, p < .01) color compo-
nents. There were significant differences in green color compo-
nents between limited (0.399 ± 0.042) and extensive (0.375 ± 
0.044) (p = .014) polymorphonuclear cell infiltration within 
MES-0. It was observed that the green color component of AFI 
decreased as the severity of the mucosal inflammation increased. 
Endocytoscopy
Endocytoscopy (Olympus, Tokyo, Japan) is a new technique, 
enabling observation of the gastrointestinal mucosa at the cellu-
lar level. Microscopic imaging for the gut mucosal layer can be 
observed at a magnification up to 1,400-fold with a contact light 
microscope.53 It requires preparation of the mucosal layer with 
absorptive contrast agents like methylene blue or toluidine blue. 
Thus, endoscopists can distinguish architectural details such as 
epithelial structure, cellular features, and vascular patterns in 
terms of size, leakage, and tortuosity.54-56 
Some studies suggest that endocytoscopy has a potential role 
in in vivo evaluation. A study in patients who have colorectal ab-
errant crypt foci demonstrated that endocystoscopy was able to 
detect tissue abnormalities in the normal mucosa surrounding 
CRC and to identify neoplasia in aberrant crypt foci with 91.4% 
sensitivity.56 A pilot study with IBD patients showed that en-
docytoscopy could reliably distinguish single inflammatory cells 
with high sensitivities and specificities (neutrophilic [60% and 
95%], basophilic [74.43% and 94.44%], eosinophilic granulo-
cytes [75% and 90.48%], and lymphocytes [88.89% and 
93.33%]). It also showed that the concordance between endo-
cytoscopy and histopathology for grading intestinal disease ac-
tivity in IBD was 100%.54 This new imaging technique intro-
duces possibilities for the development of in vivo research while 
allowing surface magnification at cellular and subcellular reso-
lution, but little data is currently available on endocytoscopy. 
CONCLUSION
Diagnostic techniques in the field of IBD including endosco-
py, molecular pathology, genetics, epigenetics, metabolomics, 
and proteomics have emerged over the past few decades. An im-
provement in endoscopic techniques has enabled precise diag-
nosis and identification of dysplasia with advanced image pro-
cessing software and optical filter technology. The two major 
advances provide better recognition of abnormalities enabling a 
refined classification and characterize the extent and depth of the 
inflammation or mucosal healing, facilitating targeted biopsy. 
Real-time microscopy during the ongoing endoscopy at a sub-
cellular resolution is noninvasive and timesaving. These features 
provide high diagnostic accuracy for the detection of disease ac-
tivity, location, severity, and complications and can provide valuable 
guidance for choosing medical and surgical treatments (Table 2). 
Despite the promising data, the generalizability of the proce-






High definition endoscopy + ++
Chromoendoscopy (dye-based) + +++
Narrow band imaging ++ ± or +
i-Scan + or ++ ++
Confocal laser endomicroscopy ++ ++
Autofluorescence imaging ± ++
Endocytoscopy ++ ± or +
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dure should be confirmed with more well designed clinical in-
vestigations. Moreover, the utility of these techniques are depen-
dent on the skill of the observers, so it is practically impossible 
to avoid “intra-observer variation” and “inter-observer variation.” 
The new endoscopic imaging modalities used in clinical prac-
tice still warrant further investigation. In addition, even if en-
doscopy in IBD patients is clear, final diagnosis of intraepitheli-
al neoplasia and disease activity still remains on histopathology. It 
will be important to identify the challenges associated with imple-
menting these advanced endoscopy techniques in clinical practice. 
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